Bronnen:
- Khorana AA, Soff GA, Kakkar AK, et al. Rivaroxaban thromboprophylaxis in high-risk ambulatory cancer patients receiving systemic therapy: results of a randomized clinical trial (CASSINI). ASH Annual Meeting and Exposition 2018, abstract LBA-1.